Listed

Petmed Express Inc: Form 10-Q for the period ended Dec 31, 2020

Filed with the SEC on Jan 26, 2021 and accepted by EDGAR at Jan 26, 2021, 12:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-10-01 to 2020-12-31$65.9mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Revenue9 months2020-04-01 to 2020-12-31$237.5mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2020-10-01 to 2020-12-31$46.3mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2020-04-01 to 2020-12-31$168.1mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-10-01 to 2020-12-31$19.6mus-gaap:GrossProfit
Gross profit9 months2020-04-01 to 2020-12-31$69.4mus-gaap:GrossProfit
Operating income3 months2020-10-01 to 2020-12-31$9.3mus-gaap:OperatingIncomeLoss
Operating income9 months2020-04-01 to 2020-12-31$29.2mus-gaap:OperatingIncomeLoss
Income tax3 months2020-10-01 to 2020-12-31$2.1mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2020-04-01 to 2020-12-31$6.6mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-10-01 to 2020-12-31$7.6mus-gaap:NetIncomeLoss
Net income9 months2020-04-01 to 2020-12-31$23.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-10-01 to 2020-12-31$0.38us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2020-04-01 to 2020-12-31$1.18us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-10-01 to 2020-12-31$0.38us-gaap:EarningsPerShareBasic
Basic EPS9 months2020-04-01 to 2020-12-31$1.19us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-10-01 to 2020-12-3120,104,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2020-04-01 to 2020-12-3120,100,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2020-04-01 to 2020-12-31$21.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2020-04-01 to 2020-12-31$1.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2020-04-01 to 2020-12-31$17.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2020-04-01 to 2020-12-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-12-31$106.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$141.0mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$167.4mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$26.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$28.2mus-gaap:Liabilities
Shareholders' equityAt period end2020-12-31$139.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-21-001245. Last ingested by Listed: Nov 13, 2026, 14:26 ET. Listed shows no prices and gives no investment advice.